6550--NEW - Non Gyn Specimen Processing Lease & Consumables
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
257-NETWORK CONTRACT OFFICE 17 (36C257)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36C25726Q0411
NAICS
325413 - In-Vitro Diagnostic Substance Manufacturing
Classification Code
6550
Additional Details
Documents4
The Department of Veterans Affairs, through its 257-Network Contract Office 17, has issued a combined synopsis/solicitation for the procurement titled "6550--NEW - Non Gyn Specimen Processing Lease & Consumables" (Solicitation Number: 36C25726Q0411). This procurement seeks to secure a lease agreement and associated consumables for non-gynecological specimen processing, supporting the clinical and diagnostic operations at the VA facility located in Harlingen, Texas.
The primary objective of this solicitation is to obtain reliable, high-quality in-vitro diagnostic solutions that facilitate the processing of non-gynecological specimens. The scope encompasses both the leasing of necessary equipment and the ongoing supply of consumables required for uninterrupted laboratory operations. The intended outcome is to enhance the facility’s diagnostic capabilities, ensuring timely and accurate specimen analysis for veteran patients.
Key requirements include the provision of equipment and consumables that meet the standards outlined under NAICS Code 325413 (In-Vitro Diagnostic Substance Manufacturing) and Product Service Code 6550. Offerors are expected to deliver products and services that comply with all applicable specifications, terms, and conditions as detailed in the solicitation documents. The procurement is classified under the 2022 NAICS version and is specifically targeted at vendors with expertise in manufacturing and supplying in-vitro diagnostic substances.
The place of performance for this contract is Harlingen, Texas, within the United States. The contracting activity is managed by the 257-Network Contract Office 17, a federal office under the Department of Veterans Affairs. Interested parties should direct all inquiries and submissions to the primary point of contact, Ognian D. Ivanov, who can be reached via email at [email protected] or by phone at 210-694-6302.
This notice serves as an amendment to the original solicitation, specifically extending the quotation submission deadline from May 15, 2026, to May 20, 2026, at 10:00 AM Central Time. All other terms, conditions, and specifications remain unchanged. Offerors are required to acknowledge receipt of this amendment as per the solicitation instructions to ensure their proposals are considered responsive.
The opportunity remains active and is accessible through the official SAM.gov portal (Opportunity ID: 644008fe46f945b5898ba02fe1b2fad8). Contractors are encouraged to review all attached documents for comprehensive requirements and to ensure alignment with their capabilities and experience in the field of in-vitro diagnostic substance manufacturing and laboratory support services.